Tronox Holdings (NYSE: TROX) posts higher sales but deeper Q2 loss
Tronox Holdings plc reported Q2 2026 revenue of $868 million, up 19% year over year and 14% sequentially, led by TiO2 revenue of $700 million and zircon revenue of $97 million. Strong volume growth offset weaker zircon pricing, but profitability remained pressured: net loss attributable to Tronox widened to $171 million, or $(1.07) per diluted share. Adjusted net loss was $82 million, or $(0.51) per share. Adjusted EBITDA fell 22% to $73 million, with margin declining to 8.4%, though EBITDA improved 18% versus Q1.
Free cash flow turned positive at $60 million for the quarter, supported by about $120 million of inventory reduction and capital expenditures of $45 million. Total debt was $3.2 billion and net debt $3.0 billion, with available liquidity of $527 million and net leverage at 11.4x trailing Adjusted EBITDA. Management guides Q3 2026 Adjusted EBITDA to $95–$115 million, expects TiO2 and zircon pricing to increase sequentially despite modest volume moderation, and continues to target meaningful positive free cash flow for full-year 2026 while advancing its rare earths strategy.
Positive
- Q2 2026 revenue grew 19% year over year to $868 million, with TiO2 and zircon volumes significantly higher.
- Quarterly free cash flow reached $60 million, a marked improvement from prior negative levels, aided by roughly $120 million inventory reduction.
Negative
- Adjusted EBITDA declined 22% year over year to $73 million, and margin compressed from 12.7% to 8.4%.
- Net loss attributable to Tronox widened to $171 million, or $(1.07) per diluted share, and net leverage rose to 11.4x trailing Adjusted EBITDA.
Filing Explained
As of June 30, Tronox reported a higher share count without establishing issuance terms, while first-half free cash flow remained negative.
Tronox Holdings plc uses this Form 8-K to furnish its completed second-quarter 2026 results through Exhibit 99.1; the exhibit is not deemed filed or incorporated by reference under the stated conditions. The release reports
Issuing additional shares increases the total share count and reduces an existing holder’s percentage ownership absent offsetting changes. This 8-K reports the two share counts but does not establish that the increase resulted from an issuance or provide terms that quantify dilution.
Second-quarter free cash flow was positive, while six-month free cash flow remained negative; six-month operating cash flow was positive. The company also reports replacing an expired short-term revolving facility with a new long-term financing arrangement, with the next significant debt maturity not until
A specified future milestone is completion of the definitive feasibility study for the rare-earths cracking and leaching facility, expected by the third quarter of
8-K Event Classification
Key Figures
Key Terms
Adjusted EBITDA financial
Free cash flow financial
net leverage ratio financial
accounts receivable securitization program financial
asset retirement obligations financial
Earnings Snapshot
For Q3 2026, the company expects Adjusted EBITDA of $95–$115 million, higher TiO2 and zircon pricing with modest volume moderation, and relatively neutral free cash flow, while reaffirming expectations for meaningful positive free cash flow for full-year 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What were Tronox (TROX) Q2 2026 revenue and profit results?
How did TiO2 and zircon businesses perform for Tronox (TROX) in Q2 2026?
What was Tronox (TROX) Q2 2026 Adjusted EBITDA and margin?
What are Tronox (TROX) debt, liquidity and leverage figures as of June 30, 2026?
What outlook and guidance did Tronox (TROX) provide for Q3 and full-year 2026?
|
|
|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
Laporte Road, Stallingborough
|
|
|
|
Grimsby, North East Lincolnshire, DN40 2PR, UK
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading Symbol(s)
|
Name of exchange on which registered
|
| Item 2.02. |
Results of Operations and Financial Condition.
|
| Item 9.01. |
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Earnings Release, dated August 5, 2026.
|
|
|
104
|
Inline XBRL for the cover page of this Current Report on Form 8-K.
|
|
TRONOX HOLDINGS PLC
|
|||
|
Date: August 6, 2026
|
By:
|
/s/ Jeffrey N. Neuman
|
|
|
Name: Jeffrey N. Neuman
|
|||
|
Title: Senior Vice President, General Counsel and Secretary
|
Exhibit 99.1

| • |
Revenue of $868 million, a 14% increase compared to the prior quarter and a 19% increase compared to the prior year
|
| • |
Loss from operations of $21 million; net loss attributable to Tronox of $171 million (including $103 million tax valuation allowance); adjusted net loss attributable to Tronox was $82 million (non-GAAP)
|
| • |
GAAP diluted loss per share was $1.07; Adjusted diluted loss per share was $0.51 (non-GAAP)
|
| • |
Adjusted EBITDA of $73 million; Adjusted EBITDA margin of 8.4% (non-GAAP)
|
| • |
Capital expenditures of $45 million
|
| • |
Generated free cash flow of $60 million
|
| • |
Expect to deliver meaningful positive free cash flow for full year 2026, with Q3 relatively neutral
|
| • |
Expect Q3 2026 TiO2 volumes to be down moderately, in the mid-single-digit percentage range, in-line with normal, seasonal patterns
|
| • |
Expect Q3 zircon volumes to moderate slightly compared to Q2, due to inventory availability following a very strong first half
|
| • |
TiO2 pricing expected to improve sequentially in the mid-single-digit percentage range and zircon pricing to improve in the mid- to high single-digit percentage range in
Q3 2026
|
| • |
Q3 2026 Adjusted EBITDA expected to be $95-$115 million
|
|
|
1 | Page
|
|
($M unless otherwise noted)
|
Q2 2026
|
Q2 2025
|
Y-o-Y%∆
|
|
Q1 2026
|
Q-o-Q%∆
|
|
|||||||||||
|
Revenue
|
$
|
868
|
$
|
731
|
19
|
%
|
$
|
760
|
14
|
%
|
||||||||
|
TiO2
|
$
|
700
|
$
|
587
|
19
|
%
|
$
|
616
|
14
|
%
|
||||||||
|
Zircon
|
$
|
97
|
$
|
68
|
43
|
%
|
$
|
89
|
9
|
%
|
||||||||
|
Other products
|
$
|
71
|
$
|
76
|
(7
|
)%
|
$
|
55
|
29
|
%
|
||||||||
|
(Loss) from operations
|
$
|
(21
|
)
|
$
|
(35
|
)
|
n/
|
m
|
$
|
(41
|
)
|
n/
|
m
|
|||||
|
Net (loss) attributable to Tronox
|
$
|
(171
|
)
|
$
|
(84
|
)
|
n/
|
m
|
$
|
(103
|
)
|
n/
|
m
|
|||||
|
GAAP diluted (loss) per share
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
n/
|
m
|
$
|
(0.65
|
)
|
n/
|
m
|
|||||
|
Adjusted diluted (loss) per share
|
$
|
(0.51
|
)
|
$
|
(0.28
|
)
|
n/
|
m
|
$
|
(0.55
|
)
|
n/
|
m
|
|||||
|
Adjusted EBITDA
|
$
|
73
|
$
|
93
|
(22
|
)%
|
$
|
62
|
18
|
%
|
||||||||
|
Adjusted EBITDA Margin %
|
8.4
|
%
|
12.7
|
%
|
(430) bps
|
8.2
|
%
|
20 bps
|
||||||||||
|
Free cash flow
|
$
|
60
|
$
|
(55
|
)
|
n/
|
m
|
$
|
(135
|
)
|
n/
|
m
|
|
Y-o-Y % ∆
|
Q-o-Q % ∆
|
|||||
|
Volume
|
Price / Mix
|
FX
|
Volume
|
Price / Mix
|
FX
|
|
|
TiO2
|
18 %
|
0%
|
1%
|
9 %
|
5 %
|
0 %
|
|
Zircon
|
61 %
|
(18)%
|
—
|
4 %
|
5 %
|
—
|
|
|
2 | Page
|
|
|
3 | Page
|
|
|
4 | Page
|
|
|
5 | Page
|
|
|
6 | Page
|
|
|
7 | Page
|
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
Net sales
|
$
|
868
|
$
|
731
|
$
|
1,628
|
$
|
1,469
|
||||||||
|
Cost of goods sold
|
813
|
652
|
1,529
|
1,291
|
||||||||||||
|
Gross profit
|
55
|
79
|
99
|
178
|
||||||||||||
|
Restructuring and other charges
|
4
|
42
|
18
|
128
|
||||||||||||
|
Selling, general and administrative expenses
|
72
|
72
|
143
|
146
|
||||||||||||
|
Loss from operations
|
(21
|
)
|
(35
|
)
|
(62
|
)
|
(96
|
)
|
||||||||
|
Interest expense
|
(56
|
)
|
(45
|
)
|
(109
|
)
|
(87
|
)
|
||||||||
|
Interest income
|
—
|
1
|
2
|
3
|
||||||||||||
|
Other income (expense), net
|
10
|
(2
|
)
|
(2
|
)
|
(7
|
)
|
|||||||||
|
Loss before income taxes
|
(67
|
)
|
(81
|
)
|
(171
|
)
|
(187
|
)
|
||||||||
|
Income tax provision
|
(106
|
)
|
(4
|
)
|
(106
|
)
|
(9
|
)
|
||||||||
|
Net loss
|
(173
|
)
|
(85
|
)
|
(277
|
)
|
(196
|
)
|
||||||||
|
Net loss attributable to noncontrolling interest
|
(2
|
)
|
(1
|
)
|
(3
|
)
|
(1
|
)
|
||||||||
|
Net loss attributable to Tronox Holdings plc
|
$
|
(171
|
)
|
$
|
(84
|
)
|
$
|
(274
|
)
|
$
|
(195
|
)
|
||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Loss per share:
|
||||||||||||||||
|
Basic
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
$
|
(1.72
|
)
|
$
|
(1.23
|
)
|
||||
|
Diluted
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
$
|
(1.72
|
)
|
$
|
(1.23
|
)
|
||||
|
|
||||||||||||||||
|
Weighted average shares outstanding, basic (in thousands)
|
159,841
|
158,561
|
159,444
|
158,358
|
||||||||||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,841
|
158,561
|
159,444
|
158,358
|
||||||||||||
|
|
||||||||||||||||
|
Other Operating Data:
|
||||||||||||||||
|
Capital expenditures
|
45
|
83
|
112
|
193
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
74
|
151
|
145
|
||||||||||||
|
|
8 | Page
|
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
|
||||||||||||||||
|
Net loss attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
(171
|
)
|
$
|
(84
|
)
|
$
|
(274
|
)
|
$
|
(195
|
)
|
||||
|
Gain on sale of Fuzhou (a)
|
(20
|
)
|
—
|
(20
|
)
|
—
|
||||||||||
|
Restructuring and other charges (b)
|
4
|
38
|
18
|
124
|
||||||||||||
|
Tax valuation allowance (c)
|
103
|
—
|
103
|
—
|
||||||||||||
|
Other (d)
|
2
|
1
|
3
|
2
|
||||||||||||
|
Adjusted net loss attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
(82
|
)
|
$
|
(45
|
)
|
$
|
(170
|
)
|
$
|
(69
|
)
|
||||
|
Diluted net loss per share (U.S. GAAP)
|
$
|
(1.07
|
)
|
$
|
(0.53
|
)
|
$
|
(1.72
|
)
|
$
|
(1.23
|
)
|
||||
|
Gain on sale of Fuzhou, per share
|
(0.13
|
)
|
—
|
(0.13
|
)
|
—
|
||||||||||
|
Restructuring and other charges, per share
|
0.03
|
0.24
|
0.12
|
0.78
|
||||||||||||
|
Tax valuation allowance, per share
|
0.65
|
—
|
0.65
|
—
|
||||||||||||
|
Other, per share
|
0.01
|
0.01
|
0.01
|
0.01
|
||||||||||||
|
Diluted adjusted net loss per share attributable to Tronox Holdings plc (non-U.S. GAAP) (1)
|
$
|
(0.51
|
)
|
$
|
(0.28
|
)
|
$
|
(1.07
|
)
|
$
|
(0.44
|
)
|
||||
|
Weighted average shares outstanding, diluted (in thousands)
|
159,841
|
158,561
|
159,444
|
158,358
|
||||||||||||
|
|
9 | Page
|
|
|
June 30, 2026
|
December 31, 2025
|
||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash and cash equivalents
|
$
|
194
|
$
|
199
|
||||
|
Restricted cash
|
12
|
12
|
||||||
|
Accounts receivable (net of allowance for credit losses of $1 and $1 as of June 30, 2026 and December 31, 2025,
respectively)
|
363
|
289
|
||||||
|
Inventories, net
|
1,458
|
1,652
|
||||||
|
Prepaid and other assets
|
113
|
112
|
||||||
|
Income taxes receivable
|
1
|
1
|
||||||
|
Total current assets
|
2,141
|
2,265
|
||||||
|
Noncurrent Assets
|
||||||||
|
Property, plant and equipment, net
|
1,988
|
2,007
|
||||||
|
Mineral leaseholds, net
|
595
|
608
|
||||||
|
Intangible assets, net
|
203
|
214
|
||||||
|
Lease right of use assets, net
|
180
|
173
|
||||||
|
Deferred tax assets
|
727
|
833
|
||||||
|
Other long-term assets
|
116
|
117
|
||||||
|
Total assets
|
$
|
5,950
|
$
|
6,217
|
||||
|
LIABILITIES AND EQUITY
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable
|
$
|
404
|
$
|
481
|
||||
|
Accrued liabilities
|
254
|
274
|
||||||
|
Short-term lease liabilities
|
24
|
22
|
||||||
|
Obligations under inventory financing arrangement
|
50
|
50
|
||||||
|
Short-term debt
|
68
|
51
|
||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
Income taxes payable
|
1
|
2
|
||||||
|
Total current liabilities
|
840
|
919
|
||||||
|
Noncurrent Liabilities
|
||||||||
|
Long-term debt, net
|
3,123
|
3,132
|
||||||
|
Pension and postretirement healthcare benefits
|
80
|
81
|
||||||
|
Asset retirement obligations
|
209
|
198
|
||||||
|
Environmental liabilities
|
30
|
39
|
||||||
|
Long-term lease liabilities
|
156
|
148
|
||||||
|
Deferred tax liabilities
|
212
|
208
|
||||||
|
Other long-term liabilities
|
109
|
43
|
||||||
|
Total liabilities
|
4,759
|
4,768
|
||||||
|
Commitments and Contingencies
|
||||||||
|
Shareholders’ Equity
|
||||||||
|
Tronox Holdings plc ordinary shares, par value $0.01 — 159,700,029 shares issued and outstanding at June 30, 2026 and
158,557,858 shares issued and outstanding at December 31, 2025
|
2
|
2
|
||||||
|
Capital in excess of par value
|
2,097
|
2,103
|
||||||
|
(Accumulated deficit) retained earnings
|
(244
|
)
|
30
|
|||||
|
Accumulated other comprehensive loss
|
(694
|
)
|
(717
|
)
|
||||
|
Total Tronox Holdings plc shareholders’ equity
|
1,161
|
1,418
|
||||||
|
Noncontrolling interest
|
30
|
31
|
||||||
|
Total equity
|
1,191
|
1,449
|
||||||
|
Total liabilities and equity
|
$
|
5,950
|
$
|
6,217
|
||||
|
|
10 | Page
|
|
|
Six Months Ended June 30,
|
|||||||
|
|
2026
|
2025
|
||||||
|
Cash Flows from Operating Activities:
|
||||||||
|
Net loss
|
$
|
(277
|
)
|
$
|
(196
|
)
|
||
|
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
|
||||||||
|
Depreciation, depletion and amortization
|
151
|
145
|
||||||
|
Deferred income taxes
|
106
|
7
|
||||||
|
Share-based compensation expense
|
11
|
9
|
||||||
|
Amortization of deferred debt issuance costs and discount on debt
|
6
|
5
|
||||||
|
Restructuring and other charges
|
18
|
128
|
||||||
|
Other non-cash items affecting net loss
|
9
|
29
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Increase in accounts receivable, net of allowance for credit losses
|
(74
|
)
|
(19
|
)
|
||||
|
Decrease (increase) in inventories, net
|
191
|
(76
|
)
|
|||||
|
Decrease in prepaid and other assets
|
21
|
29
|
||||||
|
Restructuring payments
|
(29
|
)
|
(27
|
)
|
||||
|
Decrease in accounts payable and accrued liabilities
|
(84
|
)
|
(23
|
)
|
||||
|
Net changes in income tax payables and receivables
|
-
|
(5
|
)
|
|||||
|
Changes in other non-current assets and liabilities
|
(12
|
)
|
(10
|
)
|
||||
|
Cash provided by (used in) operating activities
|
37
|
(4
|
)
|
|||||
|
Cash Flows from Investing Activities:
|
||||||||
|
Capital expenditures
|
(112
|
)
|
(193
|
)
|
||||
|
Loans
|
-
|
15
|
||||||
|
Proceeds from dispositions and asset sales
|
15
|
2
|
||||||
|
Cash used in investing activities
|
(97
|
)
|
(176
|
)
|
||||
|
Cash Flows from Financing Activities:
|
||||||||
|
Repayments of short-term debt
|
(99
|
)
|
(11
|
)
|
||||
|
Repayments of long-term debt
|
(16
|
)
|
(14
|
)
|
||||
|
Repayments of inventory financing arrangement
|
(50
|
)
|
-
|
|||||
|
Proceeds from inventory financing arrangement
|
50
|
-
|
||||||
|
Proceeds from sale and leaseback transaction
|
75
|
-
|
||||||
|
Proceeds from short-term debt
|
116
|
203
|
||||||
|
Debt issuance costs
|
(2
|
)
|
(1
|
)
|
||||
|
Sale and leaseback transaction costs
|
(1
|
)
|
-
|
|||||
|
Dividends paid
|
(16
|
)
|
(20
|
)
|
||||
|
Restricted stock and performance-based shares settled in cash for withholding taxes
|
-
|
(1
|
)
|
|||||
|
Cash provided by financing activities
|
57
|
156
|
||||||
|
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(2
|
)
|
5
|
|||||
|
Net decrease in cash and cash equivalents and restricted cash
|
(5
|
)
|
(19
|
)
|
||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
211
|
152
|
||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
206
|
$
|
133
|
||||
|
|
11 | Page
|
|
|
Three Months Ended June 30,
|
Six Months Ended June 30,
|
||||||||||||||
|
|
2026
|
2025
|
2026
|
2025
|
||||||||||||
|
|
||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(173
|
)
|
$
|
(85
|
)
|
$
|
(277
|
)
|
$
|
(196
|
)
|
||||
|
Interest expense
|
56
|
45
|
109
|
87
|
||||||||||||
|
Interest income
|
—
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
|||||||||
|
Income tax provision
|
106
|
4
|
106
|
9
|
||||||||||||
|
Depreciation, depletion and amortization expense
|
76
|
74
|
151
|
145
|
||||||||||||
|
EBITDA (non-U.S. GAAP)
|
65
|
37
|
87
|
42
|
||||||||||||
|
Gain on sale of Fuzhou (a)
|
(20
|
)
|
—
|
(20
|
)
|
—
|
||||||||||
|
Share-based compensation (b)
|
5
|
4
|
11
|
9
|
||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (c)
|
6
|
7
|
10
|
14
|
||||||||||||
|
Accounts receivable securitization program (d)
|
4
|
3
|
7
|
7
|
||||||||||||
|
Foreign currency remeasurement (e)
|
7
|
(2
|
)
|
14
|
(1
|
)
|
||||||||||
|
Restructuring and other charges (f)
|
4
|
42
|
18
|
128
|
||||||||||||
|
Other items (g)
|
2
|
2
|
8
|
6
|
||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
73
|
$
|
93
|
$
|
135
|
$
|
205
|
||||||||
|
|
Three Months Ended June 30,
|
|||||||
|
|
2026
|
2025
|
||||||
|
Net sales
|
$
|
868
|
|
$
|
731
|
|
||
|
Net loss (U.S. GAAP)
|
$ |
(173
|
) |
$ |
(85
|
) |
||
|
Net loss (U.S. GAAP) as a % of Net sales
|
(19.9
|
)% |
(11.6
|
)%
|
||||
|
Adjusted EBITDA (non-U.S. GAAP) (see above) as a % of Net sales
|
8.4
|
% |
12.7
|
% |
||||
|
|
|
|
||||||
|
|
June 30, 2026
|
December 31, 2025
|
||||||
|
Long-term debt, net
|
$ |
3,123
|
|
$ |
3,132
|
|||
|
Short-term debt
|
68
|
51 | ||||||
|
Long-term debt due within one year
|
39
|
39
|
||||||
|
(Less) Cash and cash equivalents
|
(194
|
) |
(199
|
) |
||||
|
Net debt (1)
|
$ |
3,036
|
$ |
3,023
|
|
|||
|
Trailing-twelve month Adjusted EBITDA (non-U.S. GAAP)
|
$ |
266
|
$ |
336
|
||||
|
Net debt to trailing-twelve month Adjusted EBITDA (non-U.S. GAAP) (see above)
|
11.4
|
x |
9.0 |
x |
||||
|
|
12 | Page
|
|
|
Six Months Ended
June 30, 2026
|
Three Months Ended
March 31, 2026 |
Three Months Ended
June 30, 2026
|
|||||||||
|
Cash used in operating activities
|
$
|
37
|
$
|
(68
|
)
|
$
|
105
|
|||||
|
Capital expenditures
|
(112
|
)
|
(67
|
)
|
(45
|
)
|
||||||
|
Free cash flow (non-U.S. GAAP)
|
$
|
(75
|
)
|
$
|
(135
|
)
|
$
|
60
|
||||
|
|
13 | Page
|
|
|
Three Months Ended
|
Trailing Twelve Month
|
||||||||||||||||||
|
|
September 30, 2025
|
December 31, 2025
|
March 31, 2026
|
June 30, 2026
|
Adjusted EBITDA
|
|||||||||||||||
|
|
||||||||||||||||||||
|
Net loss (U.S. GAAP)
|
$
|
(100
|
)
|
$
|
(177
|
)
|
$
|
(104
|
)
|
$
|
(173
|
)
|
$
|
(554
|
)
|
|||||
|
Interest expense
|
48
|
54
|
53
|
56
|
211
|
|||||||||||||||
|
Interest income
|
(1
|
)
|
(2
|
)
|
(2
|
)
|
—
|
(5
|
)
|
|||||||||||
|
Income tax provision (benefit)
|
8
|
(2
|
)
|
—
|
106
|
112
|
||||||||||||||
|
Depreciation, depletion and amortization expense
|
75
|
82
|
75
|
76
|
308
|
|||||||||||||||
|
EBITDA (non-U.S. GAAP)
|
30
|
(45
|
)
|
22
|
65
|
72
|
||||||||||||||
|
Gain on sale of Fuzhou (a)
|
—
|
—
|
—
|
(20
|
)
|
(20
|
)
|
|||||||||||||
|
Share-based compensation (b)
|
5
|
6
|
6
|
5
|
22
|
|||||||||||||||
|
Foreign currency remeasurement (c)
|
—
|
7
|
7
|
7
|
21
|
|||||||||||||||
|
Accretion expense and other adjustments to asset retirement obligations and environmental liabilities (d)
|
6
|
(11
|
)
|
4
|
6
|
5
|
||||||||||||||
|
Accounts receivable securitization program (e)
|
3
|
3
|
3
|
4
|
13
|
|||||||||||||||
|
Restructuring and other charges (f)
|
25
|
79
|
14
|
4
|
122
|
|||||||||||||||
|
Other items (g)
|
5
|
18
|
6
|
2
|
31
|
|||||||||||||||
|
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
74
|
$
|
57
|
$
|
62
|
$
|
73
|
$
|
266
|
||||||||||
|
|
14 | Page
|